Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.7375
-0.0155 (-2.06%)
At close: Aug 10, 2026, 4:00 PM EDT
0.7105
-0.0270 (-3.66%)
After-hours: Aug 10, 2026, 5:03 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $68.57 million as of August 10, 2026. Its market cap has decreased by -51.66% in one year.
Market Cap
68.57M
Enterprise Value
69.74M
1-Year Change
-51.66%
Ranking
Category
Stock Price
$0.74
ChartMarket Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $68.57M, a decrease of -23.99%. That is a compound annual growth rate of -7.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 68.57M | -19.13% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 164.58M |
| ADC Therapeutics | 143.73M |
| Organigram Global | 138.38M |
| BGM Group | 120.35M |
| Cumberland Pharmaceuticals | 116.87M |
| Zhengye Biotechnology Holding | 89.57M |
| Talphera | 74.22M |
| InterCure | 53.97M |